Singapore: Invida Holdings, a biopharmaceutical commercialization company based in Singapore, is changing its name to A ...
Embryonic stem (ES) cells possess unique therapeutic potential due to their ability to give rise to all the cells of the...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr Andrew Cunningham as vice president of central labo...
Singapore: DIA will conduct the Asia Regulatory Conference 2013 at Raffles City Convention Center in Singapore during Ja...
Singapore: Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories have launched VereTrop, the fir...
Singapore: US-based MediPurpose, a master distributor and manufacturer of medical products, has announced an addition to...
Singapore: Singapore has launched medtech portal, www.medtech.sg, that aims to address international investors' queries ...
Singapore: The pioneer initiative brings together nanotechnology suppliers and manufacturers to speed up productization ...
Singapore: A*STAR's Institute of Bioengineering and Nanotechnology (IBN) executive director Professor Jackie Y Ying has...
Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by phar...
Singapore: The Asia Pacific (APAC) medical device market touched an estimated $54.5 billion at the beginning of 2012....
Singapore: Fab'entech, a French biopharmaceutical company specialized in developing specific polyclonal immunoglobulins...
According to industry estimates, healthcare cold-chain market is growing by 10 percent per year since companies producin...
Singapore: Agilent Technologies, which was founded in 1999, is synonymous with the R&D of liquid chromatography/gas ...
Singapore: The research and clinical communities are constantly seeking new technologies that provide faster, more accur...
China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which ...
Big news in 2013 will be the growth of biosimilars in the biologics segment. By the end of the year, biosimilars will ac...
While many multinational companies have reduced their manpower to cut costs in 2011, regional companies in Asia have gon...
